 determine clinical or economic
outcomes, the frequency of application remains at the
discretion of the clinician. Current clinical practice has
included application of grafts followed by a period of 1
to 3 weeks of observation to determine effectiveness before
reapplication is considered.
Guideline 4.23: Tissue Matrices, Human Tissues,
or Other Skin Substitutes
We suggest the use of a porcine small intestinal submucosa tissue construct in addition